SIRT6 as a transcriptomic aging biomarker: a systematic evaluation
A multi-species transcriptomic database of SIRT6 perturbation experiments found SIRT6 expression generally stable during normal aging but dysregulated in Alzheimer's disease in a cell-type and stage-specific way, so its value as an aging biomarker appears context-dependent. [1]
Automatic summary · not editorially reviewed
The key findings
SIRT6 has been linked to aging through associations with several hallmarks of aging, but the available evidence is largely context-dependent and mechanistic. [1]
The authors built SIRT6.db, a multi-species transcriptomic resource integrating SIRT6-targeted perturbation experiments from SIRT6-related publications. [1]
SIRT6 expression is generally stable during normal aging but becomes dysregulated in Alzheimer's disease in a cell-type and stage-specific manner. [1]
The source at a glance
- Study type / format
- Systematic transcriptomic database analysis (abstract)
- Population / context
- SIRT6 perturbation experiments across multiple species and biological systems, plus SIRT6 expression in normal aging and Alzheimer's disease.
- Summary based on
- Study abstract
- Publication status
- Preprint · peer-review status not confirmed
- Original publication
- September 7, 2026
SIRT6 links to aging hallmarks but evidence is context-dependent
SIRT6 is a NAD+-dependent sirtuin involved in chromatin regulation, DNA repair, telomere maintenance, metabolic homeostasis and inflammatory control. The authors note it has long been linked to aging through associations with several hallmarks of aging, but that the available evidence is largely context-dependent and mechanistic. This limits how far SIRT6 can be read as a robust, evolutionarily conserved biomarker of aging.
Supporting source [1]
Multi-species database built from SIRT6 literature
To investigate SIRT6 as an aging biomarker, the authors built SIRT6.db, a multi-species transcriptomic resource. It integrates SIRT6-targeted perturbation experiments across diverse biological systems and organisms, drawn from SIRT6-related publications collected through a large-scale textual analysis of the SIRT6 literature using topic modeling. On this basis they identified species-specific and evolutionarily conserved transcriptional and functional signatures linked to SIRT6 perturbation and related them to hallmarks of aging.
Supporting source [1]
Stable in normal aging, altered in Alzheimer's disease
The analysis showed that SIRT6 expression is generally stable during normal aging. In Alzheimer's disease, however, it becomes dysregulated in a cell-type and stage-specific manner. The authors present this contrast as highlighting the context dependence of SIRT6's potential as a transcriptomic biomarker of aging. These are transcriptomic associations, not evidence that SIRT6 causes aging or Alzheimer's disease.
Supporting source [1]
How to interpret this
This is an abstract; the full text was not reviewed. The database integrates perturbation experiments from publications, and the reported signatures are transcriptomic associations rather than causal or clinical evidence.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Kashuk E, Tarakanova A, Malygina A, Kuzovkina N, Ponomareva A, Toiber D, Khrameeva E, Smirnov D. · europepmc.org · September 7, 2026